Dark | Light
# Elicio Therapeutics, Inc. (ELTX)

ELTX stock hits all-time high driven by positive social sentiment and anticipation of clinical trial results for its mKRAS vaccine. The company's stock price has surged, reaching a 52-week and all-time high.

### About Elicio Therapeutics, Inc.
Elicio Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on developing transformative immunotherapies for cancer.  
Elicio Therapeutics, Inc. uses the ticker $ELTX for trading. Listed in the [Stocks](/list/stocks) category.

### Insights
- Elicio Therapeutics, Inc. (ELTX) mentions hit [---] which is 360% higher than it's daily average.
- Elicio Therapeutics, Inc. (ELTX) creators hit [--] which is 133% higher than it's daily average.
- Elicio Therapeutics, Inc. (ELTX) trading volume is up 2186.69% from the previous month.
- Elicio Therapeutics, Inc. (ELTX) social dominance is up 900% from the previous month.
- Elicio Therapeutics, Inc. (ELTX) Galaxy Score™ is up 292.31% from the previous [--] months.
- Elicio Therapeutics, Inc. (ELTX) creators is up 55% from the previous week.
- Elicio Therapeutics, Inc. (ELTX) engagements is up 74.34% from the previous month.
- Elicio Therapeutics, Inc. (ELTX) mentions is up 56.41% from the previous week.
- Elicio Therapeutics, Inc. Galaxy Score™ hit a 52-Week high of [--] for the hour
- Elicio Therapeutics, Inc. Price hit a 52-Week high of $9.60 for the hour
- Elicio Therapeutics, Inc. Price hit an all time of $9.60 for the hour

### Price: $8.60
![Price Line Chart](https://lunarcrush.com/gi/w:600/t:$eltx/c:line/m:close/iv:1d.svg)  
[Price 24-Hour Time-Series Raw Data](/topic/$eltx/time-series/close.tsv)  
The stock price has surged to a 52-week and all-time high, likely fueled by anticipation of upcoming clinical trial results and the potential of its therapeutic mKRAS vaccine, coinciding with significant positive social sentiment.  

24-Hour: 1.66%
7-Day: 6.81%
30-Day: 3.64%

1-Year High: $11.80 on 2025-08-22  
1-Year Low: $7.50 on 2025-06-05  
  
  
### AltRank: [-----]
![AltRank Line Chart](https://lunarcrush.com/gi/w:600/t:$eltx/c:line/m:alt_rank/iv:1d.svg)  
[AltRank 24-Hour Time-Series Raw Data](/topic/$eltx/time-series/alt_rank.tsv)  
Elicio Therapeutics, Inc. (ELTX) is currently AltRank #1,624 based on combined combined social and market metrics
Daily Average: [-----]  
[--] Week: [-----] +1,852  
1-Year High: [-----] on 2026-02-14  
1-Year Low: [---] on 2026-01-25  
  
  
### Galaxy Score: [-----]
![Galaxy Score Line Chart](https://lunarcrush.com/gi/w:600/t:$eltx/c:line/m:galaxy_score/iv:1d.svg)  
[Galaxy Score 24-Hour Time-Series Raw Data](/topic/$eltx/time-series/galaxy_score.tsv)  
Current Value: [-----]  
Daily Average: [--]  
[--] Week: [--] +30  
[--] Month: [--] +37  
[--] Months: [--] [---]  
[--] Year: [--] +35  
1-Year High: [--] on 2026-02-09  
1-Year Low: [--] on 2026-02-04  
  
  
### Engagements: [---] (24h)
![Engagements Line Chart](https://lunarcrush.com/gi/w:600/t:$eltx/c:line/m:interactions/iv:1d.svg)  
[Engagements 24-Hour Time-Series Raw Data](/topic/$eltx/time-series/interactions.tsv)  
Current Value: [---]  
Daily Average: [-----]  
[--] Week: [-----] +28%  
[--] Month: [------] +74%  
[--] Months: [-------] +40%  
[--] Year: [-------] +55%  
1-Year High: [------] on 2025-09-17  
1-Year Low: [--] on 2025-02-18  

Engagements by network (24h):
Reddit: [---]
News: [--]
YouTube: [--]
X: [---]

  
  
### Mentions: [---] (24h)
![Mentions Line Chart](https://lunarcrush.com/gi/w:600/t:$eltx/c:line/m:posts_active/iv:1d.svg)  
[Mentions 24-Hour Time-Series Raw Data](/topic/$eltx/time-series/posts_active.tsv)  
Current Value: [---]  
Daily Average: [--]  
[--] Week: [---] +56%  
1-Year High: [---] on 2025-07-08  
1-Year Low: [--] on 2025-02-15  

Mentions by network (24h):
Reddit: [--]
News: [--]
YouTube: [--]
X: [--]

  
  
### Creators: [--] (24h)
![Creators Line Chart](https://lunarcrush.com/gi/w:600/t:$eltx/c:line/m:contributors_active/iv:1d.svg)  
[Creators 24-Hour Time-Series Raw Data](/topic/$eltx/time-series/contributors_active.tsv)  
[--] unique social accounts have posts mentioning Elicio Therapeutics, Inc. (ELTX) in the last [--] hours which is up 133% from [--] in the previous [--] hours
Daily Average: [--]  
[--] Week: [--] +55%  
1-Year High: [---] on 2025-07-08  
1-Year Low: [--] on 2025-02-15  
  
  
### Sentiment: 95%
![Sentiment Line Chart](https://lunarcrush.com/gi/w:600/t:$eltx/c:line/m:sentiment/iv:1d.svg)  
[Sentiment 24-Hour Time-Series Raw Data](/topic/$eltx/time-series/sentiment.tsv)  
Current Value: 95%  
Daily Average: 92%  
[--] Week: 100% no change  
[--] Month: 75% -25%  
[--] Months: 75% -22%  
[--] Year: 75% -25%  
1-Year High: 100% on 2025-02-24  
1-Year Low: 20% on 2025-06-03  

Most Supportive Themes:
- Therapeutic mKRAS Vaccine Platform: (50%) Elicio Therapeutics is developing a therapeutic mKRAS vaccine platform for cancer treatment.
- Pancreatic Cancer Treatment: (30%) The company's vaccine is being highlighted as a potential revolution in pancreatic cancer treatment.
  
Most Critical Themes:
  
  
  
### Social Dominance: 0.00744%
![Social Dominance Line Chart](https://lunarcrush.com/gi/w:600/t:$eltx/c:line/m:social_dominance/iv:1d.svg)  
[Social Dominance 24-Hour Time-Series Raw Data](/topic/$eltx/time-series/social_dominance.tsv)  
Current Value: 0.00744%  
Daily Average: 0.00317%  
[--] Week: 0.00745% +0.00665%  
[--] Month: 0.006% +0.0054%  
[--] Months: 0.006% -0.0026%  
[--] Year: 0.006% +0.0051%  
1-Year High: 0.035% on 2025-07-08  
1-Year Low: 0.0001% on 2025-11-29  
  
  
### Market Dominance: 0.0001671073964525552%
![Market Dominance Line Chart](https://lunarcrush.com/gi/w:600/t:$eltx/c:line/m:market_dominance/iv:1d.svg)  
[Market Dominance 24-Hour Time-Series Raw Data](/topic/$eltx/time-series/market_dominance.tsv)  
Current Value: 0.0001671073964525552%  
Daily Average: 0%  
1-Year High: 0.00019% on 2026-02-09  
1-Year Low: 0.00015% on 2026-01-30  
  
  
### Market Cap: $147,561,475
![Market Cap Line Chart](https://lunarcrush.com/gi/w:600/t:$eltx/c:line/m:market_cap/iv:1d.svg)  
[Market Cap 24-Hour Time-Series Raw Data](/topic/$eltx/time-series/market_cap.tsv)  
Current Value: $147,561,475  
Daily Average: $140,835,830  
[--] Week: $147,561,475 +2.80%  
[--] Month: $147,561,475 +9.50%  
1-Year High: $164,129,781 on 2026-02-09  
1-Year Low: $131,165,755 on 2026-01-30

Limited data mode. Full metrics available with subscription: lunarcrush.com/pricing

Elicio Therapeutics, Inc. (ELTX)

ELTX stock hits all-time high driven by positive social sentiment and anticipation of clinical trial results for its mKRAS vaccine. The company's stock price has surged, reaching a 52-week and all-time high.

About Elicio Therapeutics, Inc.

Elicio Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on developing transformative immunotherapies for cancer.
Elicio Therapeutics, Inc. uses the ticker $ELTX for trading. Listed in the Stocks category.

Insights

  • Elicio Therapeutics, Inc. (ELTX) mentions hit [---] which is 360% higher than it's daily average.
  • Elicio Therapeutics, Inc. (ELTX) creators hit [--] which is 133% higher than it's daily average.
  • Elicio Therapeutics, Inc. (ELTX) trading volume is up 2186.69% from the previous month.
  • Elicio Therapeutics, Inc. (ELTX) social dominance is up 900% from the previous month.
  • Elicio Therapeutics, Inc. (ELTX) Galaxy Score™ is up 292.31% from the previous [--] months.
  • Elicio Therapeutics, Inc. (ELTX) creators is up 55% from the previous week.
  • Elicio Therapeutics, Inc. (ELTX) engagements is up 74.34% from the previous month.
  • Elicio Therapeutics, Inc. (ELTX) mentions is up 56.41% from the previous week.
  • Elicio Therapeutics, Inc. Galaxy Score™ hit a 52-Week high of [--] for the hour
  • Elicio Therapeutics, Inc. Price hit a 52-Week high of $9.60 for the hour
  • Elicio Therapeutics, Inc. Price hit an all time of $9.60 for the hour

Price: $8.60

Price Line Chart
Price 24-Hour Time-Series Raw Data
The stock price has surged to a 52-week and all-time high, likely fueled by anticipation of upcoming clinical trial results and the potential of its therapeutic mKRAS vaccine, coinciding with significant positive social sentiment.

24-Hour: 1.66% 7-Day: 6.81% 30-Day: 3.64%

1-Year High: $11.80 on 2025-08-22
1-Year Low: $7.50 on 2025-06-05

AltRank: [-----]

AltRank Line Chart
AltRank 24-Hour Time-Series Raw Data
Elicio Therapeutics, Inc. (ELTX) is currently AltRank #1,624 based on combined combined social and market metrics Daily Average: [-----]
[--] Week: [-----] +1,852
1-Year High: [-----] on 2026-02-14
1-Year Low: [---] on 2026-01-25

Galaxy Score: [-----]

Galaxy Score Line Chart
Galaxy Score 24-Hour Time-Series Raw Data
Current Value: [-----]
Daily Average: [--]
[--] Week: [--] +30
[--] Month: [--] +37
[--] Months: [--] [---]
[--] Year: [--] +35
1-Year High: [--] on 2026-02-09
1-Year Low: [--] on 2026-02-04

Engagements: [---] (24h)

Engagements Line Chart
Engagements 24-Hour Time-Series Raw Data
Current Value: [---]
Daily Average: [-----]
[--] Week: [-----] +28%
[--] Month: [------] +74%
[--] Months: [-------] +40%
[--] Year: [-------] +55%
1-Year High: [------] on 2025-09-17
1-Year Low: [--] on 2025-02-18

Engagements by network (24h): Reddit: [---] News: [--] YouTube: [--] X: [---]

Mentions: [---] (24h)

Mentions Line Chart
Mentions 24-Hour Time-Series Raw Data
Current Value: [---]
Daily Average: [--]
[--] Week: [---] +56%
1-Year High: [---] on 2025-07-08
1-Year Low: [--] on 2025-02-15

Mentions by network (24h): Reddit: [--] News: [--] YouTube: [--] X: [--]

Creators: [--] (24h)

Creators Line Chart
Creators 24-Hour Time-Series Raw Data
[--] unique social accounts have posts mentioning Elicio Therapeutics, Inc. (ELTX) in the last [--] hours which is up 133% from [--] in the previous [--] hours Daily Average: [--]
[--] Week: [--] +55%
1-Year High: [---] on 2025-07-08
1-Year Low: [--] on 2025-02-15

Sentiment: 95%

Sentiment Line Chart
Sentiment 24-Hour Time-Series Raw Data
Current Value: 95%
Daily Average: 92%
[--] Week: 100% no change
[--] Month: 75% -25%
[--] Months: 75% -22%
[--] Year: 75% -25%
1-Year High: 100% on 2025-02-24
1-Year Low: 20% on 2025-06-03

Most Supportive Themes:

  • Therapeutic mKRAS Vaccine Platform: (50%) Elicio Therapeutics is developing a therapeutic mKRAS vaccine platform for cancer treatment.
  • Pancreatic Cancer Treatment: (30%) The company's vaccine is being highlighted as a potential revolution in pancreatic cancer treatment.

Most Critical Themes:

Social Dominance: 0.00744%

Social Dominance Line Chart
Social Dominance 24-Hour Time-Series Raw Data
Current Value: 0.00744%
Daily Average: 0.00317%
[--] Week: 0.00745% +0.00665%
[--] Month: 0.006% +0.0054%
[--] Months: 0.006% -0.0026%
[--] Year: 0.006% +0.0051%
1-Year High: 0.035% on 2025-07-08
1-Year Low: 0.0001% on 2025-11-29

Market Dominance: 0.0001671073964525552%

Market Dominance Line Chart
Market Dominance 24-Hour Time-Series Raw Data
Current Value: 0.0001671073964525552%
Daily Average: 0%
1-Year High: 0.00019% on 2026-02-09
1-Year Low: 0.00015% on 2026-01-30

Market Cap: $147,561,475

Market Cap Line Chart
Market Cap 24-Hour Time-Series Raw Data
Current Value: $147,561,475
Daily Average: $140,835,830
[--] Week: $147,561,475 +2.80%
[--] Month: $147,561,475 +9.50%
1-Year High: $164,129,781 on 2026-02-09
1-Year Low: $131,165,755 on 2026-01-30

Limited data mode. Full metrics available with subscription: lunarcrush.com/pricing

Elicio Therapeutics, Inc. (ELTX)
/topic/$eltx